verapamil has been researched along with Pulmonary Hypertension in 51 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension." | 9.04 | Verapamil and pulmonary hypertension. ( Landmark, K; Refsum, AM; Simonsen, S; Storstein, O, 1978) |
| "The authors have investigated the haemodynamic effects of verapamil on the pulmonary circulation by 24 patients suffering from secondary pulmonary hypertension, caused by mitral and/or aortic valve diseases." | 7.67 | [Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease]. ( Kelemen, S; Marozsán, I; Szatmáry, L, 1989) |
| "A comparison of verapamil (V) and oxygen (O) effect on pulmonary artery pressures (PAP) was carried out in 7 patients with primary pulmonary hypertension (PPH)." | 7.67 | Pulmonary artery pressure changes in primary pulmonary hypertension after verapamil and oxygen. ( Bielecki, A; Brzostek, T; Dubiel, JP; Zmudka, K, 1988) |
| "Adult male Wistar rats were used for studying the effect of Ca2+ antagonist verapamil on pulmonary hypertension, right ventricular hypertrophy and the medial thickness of pulmonary arterioles, induced by intermittent high altitude (IHA) hypoxia." | 7.66 | Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy induced in rats by intermittent high altitude hypoxia. ( Ostádal, B; Pelouch, V; Procházka, J; Ressl, J; Urbanová, D; Widimský, J, 1981) |
| "In calves with hypoxic pulmonary hypertension, resistance was reduced by 40 +/- 3% with normoxia, 19 +/- 4% with verapamil, and 60 +/- 1% with hexoprenaline." | 7.65 | Reduction of bovine pulmonary hypertension by normoxia, verapamil and hexoprenaline. ( Grover, RF; McMurtry, IF; Reeves, JT; Will, DH, 1977) |
| "Chronic obstructive pulmonary disease (COPD) is associated with many health complications, including pulmonary hypertension (PH)." | 7.11 | Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. ( Behzadnia, N; Esmaeili, A; Fahimi, F; Forough, AS; Mostofi, SS; Parto, O; Pourdowlat, G, 2022) |
| "Pretreatment with verapamil inhibited thromboxane synthesis, the rise in pulmonary artery pressure and the hypoxia without affecting the transient leukopenia." | 5.27 | Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep. ( Davies, BJ; McDonald, JW; Noulty, EJ; Pisters, LL; Smallbone, BW; Taylor, NE, 1986) |
| "Treatment with Verapamil or aspirin reduced both chronic hypoxic pulmonary hypertension and the hypertrophy of the right ventricle." | 5.26 | Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. ( Kentera, D; Susić, D; Zdravković, M, 1979) |
| "We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension." | 5.04 | Verapamil and pulmonary hypertension. ( Landmark, K; Refsum, AM; Simonsen, S; Storstein, O, 1978) |
| " Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
| " Biochemical evidence suggests that pulmonary vasoconstriction results from the transmembrane flux of calcium into vascular smooth muscle; accordingly, the pulmonary pressor responses in experimental hypoxic pulmonary hypertension can be attenuated by verapamil and nifedipine." | 4.77 | Therapeutic application of calcium-channel antagonists for pulmonary hypertension. ( Packer, M, 1985) |
| "The study consisted of six groups (N=30; five rabbits/group): (1) Control with no pretreatment, monocrotaline injected groups: (solutions were perfused following termination of CPB for 60 min); (2) Control for pulmonary hypertension (PHT); (3) isoproteronol; (4) VIP 10(-6) M; (5) VIP 10(-5) M; (6) nitroglycerine." | 3.71 | The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. ( Chang, D; Gunaydin, S; Hagino, I; Imai, Y; Seo, K; Shinoka, T; Takanashi, Y, 2002) |
| "Effects of "Qi-Xue" injection (Panax ginseng, Astragalus monogholicus, Angelica sinensis), verapamil (Vp, calcium antagonist) and their combination on pulmonary arterial pressure (PAP) and heart function were studied in rats exposed to chronic hypoxia." | 3.68 | [Prevention of hypoxic pulmonary hypertension with "qi-xue" injection]. ( Zhao, L, 1990) |
| "The hemodynamic and clinical responses to calcium channel blockade with verapamil and nifedipine were compared with those of hydralazine in 12 patients with pulmonary hypertension secondary to obliterative pulmonary vascular disease." | 3.67 | Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. ( Medina, N; Packer, M; Yushak, M, 1984) |
| "Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension." | 3.67 | The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. ( Bancalari, E; Dickstein, PJ; Goldberg, RN; Trindade, O, 1984) |
| "Catheterization of the pulmonary artery and radiocirculography were used in 30 patients with chronic bronchitis (CB) in order to study changes in hemodynamics induced by intravenous injections of 5 and 10 mg verapamil or by 4-5 weeks of the treatment with finoptin and corinfar." | 3.67 | [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension]. ( Volkova, LI, 1989) |
| "The authors have investigated the haemodynamic effects of verapamil on the pulmonary circulation by 24 patients suffering from secondary pulmonary hypertension, caused by mitral and/or aortic valve diseases." | 3.67 | [Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease]. ( Kelemen, S; Marozsán, I; Szatmáry, L, 1989) |
| "A comparison of verapamil (V) and oxygen (O) effect on pulmonary artery pressures (PAP) was carried out in 7 patients with primary pulmonary hypertension (PPH)." | 3.67 | Pulmonary artery pressure changes in primary pulmonary hypertension after verapamil and oxygen. ( Bielecki, A; Brzostek, T; Dubiel, JP; Zmudka, K, 1988) |
| " verapamil administration on some indices of the hemodynamics of the greater and lesser circulation was studied in 19 patients with bronchial asthma by a multiple approach using noninvasive methods (rheopulmonography, polycardiography, tetrapolar chest rheography)." | 3.67 | [Acute hemodynamic effects of finoptin in patients with bronchial asthma complicated by pulmonary hypertension]. ( Brimkulov, NN, 1987) |
| "Adult male Wistar rats were used for studying the effect of Ca2+ antagonist verapamil on pulmonary hypertension, right ventricular hypertrophy and the medial thickness of pulmonary arterioles, induced by intermittent high altitude (IHA) hypoxia." | 3.66 | Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy induced in rats by intermittent high altitude hypoxia. ( Ostádal, B; Pelouch, V; Procházka, J; Ressl, J; Urbanová, D; Widimský, J, 1981) |
| "Clinical experience with calcium antagonists in congestive heart failure has, to date, been mainly restricted to the use of nifedipine but there is either no or only a limited extent of information available on diltiazem and verapamil." | 3.66 | Calcium antagonists in heart failure. ( Camerini, F; Klugmann, S; Salvi, A, 1983) |
| "In calves with hypoxic pulmonary hypertension, resistance was reduced by 40 +/- 3% with normoxia, 19 +/- 4% with verapamil, and 60 +/- 1% with hexoprenaline." | 3.65 | Reduction of bovine pulmonary hypertension by normoxia, verapamil and hexoprenaline. ( Grover, RF; McMurtry, IF; Reeves, JT; Will, DH, 1977) |
| "Chronic obstructive pulmonary disease (COPD) is associated with many health complications, including pulmonary hypertension (PH)." | 3.11 | Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. ( Behzadnia, N; Esmaeili, A; Fahimi, F; Forough, AS; Mostofi, SS; Parto, O; Pourdowlat, G, 2022) |
| "Pretreatment with indomethacin or verapamil was also studied, since these drugs block the increase in pulmonary arterial pressure caused by t-bu-OOH." | 1.27 | Pharmacological modification of pulmonary vascular injury: possible role of cAMP. ( Farrukh, IS; Gurtner, GH; Michael, JR, 1987) |
| "Pretreatment with verapamil inhibited thromboxane synthesis, the rise in pulmonary artery pressure and the hypoxia without affecting the transient leukopenia." | 1.27 | Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep. ( Davies, BJ; McDonald, JW; Noulty, EJ; Pisters, LL; Smallbone, BW; Taylor, NE, 1986) |
| "Treatment with Verapamil or aspirin reduced both chronic hypoxic pulmonary hypertension and the hypertrophy of the right ventricle." | 1.26 | Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. ( Kentera, D; Susić, D; Zdravković, M, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (74.51) | 18.7374 |
| 1990's | 6 (11.76) | 18.2507 |
| 2000's | 5 (9.80) | 29.6817 |
| 2010's | 1 (1.96) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| Fahimi, F | 1 |
| Pourdowlat, G | 1 |
| Behzadnia, N | 1 |
| Mostofi, SS | 1 |
| Forough, AS | 1 |
| Parto, O | 1 |
| Esmaeili, A | 1 |
| Russell, NJ | 1 |
| Irwin, PJ | 1 |
| Hopper, BJ | 1 |
| Olivry, T | 1 |
| Nicholls, PK | 1 |
| Strielkov, IeV | 1 |
| Frantsuzova, SB | 1 |
| Khromov, OS | 1 |
| Yang, Y | 1 |
| Qiao, J | 1 |
| Wang, H | 1 |
| Gao, M | 1 |
| Ou, D | 1 |
| Zhang, J | 1 |
| Sun, M | 1 |
| Yang, X | 1 |
| Zhang, X | 1 |
| Guo, Y | 1 |
| Stone, KS | 1 |
| Scordo, KA | 1 |
| Krikler, DM | 1 |
| Rowland, E | 1 |
| Ellrodt, AG | 1 |
| Singh, BN | 1 |
| Drummond, WH | 1 |
| Ostádal, B | 3 |
| Widimský, J | 3 |
| Urbanová, D | 2 |
| Procházka, J | 2 |
| Pelouch, V | 2 |
| Ressl, J | 1 |
| Packer, M | 3 |
| Medina, N | 2 |
| Yushak, M | 2 |
| Dickstein, PJ | 1 |
| Trindade, O | 1 |
| Goldberg, RN | 1 |
| Bancalari, E | 1 |
| Young, TE | 1 |
| Lundquist, LJ | 1 |
| Chesler, E | 1 |
| Weir, EK | 1 |
| Stanbrook, HS | 1 |
| Morris, KG | 1 |
| McMurtry, IF | 2 |
| Wiener, I | 1 |
| Klugmann, S | 1 |
| Salvi, A | 1 |
| Camerini, F | 1 |
| Jandová, R | 1 |
| Frídl, P | 1 |
| Dabrowski, A | 1 |
| Sclavo, M | 1 |
| Bucca, C | 1 |
| Rolla, G | 1 |
| Borello, G | 1 |
| Balbi, L | 1 |
| Angelino, PF | 1 |
| Volkova, LI | 2 |
| Shteĭngart, IuN | 1 |
| Kakhnovskiĭ, IM | 1 |
| Sivkov, SI | 1 |
| Markova, ZS | 1 |
| Ivanova, IL | 1 |
| Sivkov, AS | 1 |
| Nakazawa, H | 1 |
| Hori, M | 1 |
| Murata, T | 1 |
| Ozaki, H | 1 |
| Karaki, H | 1 |
| De Crescenzo, V | 1 |
| Dubuis, E | 1 |
| Constantin, S | 1 |
| Rebocho, M | 1 |
| Girardin, C | 1 |
| Bonnet, P | 1 |
| Vandier, C | 1 |
| Gunaydin, S | 1 |
| Imai, Y | 1 |
| Takanashi, Y | 1 |
| Seo, K | 1 |
| Hagino, I | 1 |
| Chang, D | 1 |
| Shinoka, T | 1 |
| Kentera, D | 1 |
| Susić, D | 1 |
| Zdravković, M | 1 |
| Landmark, K | 1 |
| Refsum, AM | 1 |
| Simonsen, S | 1 |
| Storstein, O | 1 |
| Davidson, A | 1 |
| McMurtry, I | 1 |
| Reeves, JT | 2 |
| Will, DH | 1 |
| Grover, RF | 1 |
| Poloński, L | 2 |
| Polońska, A | 2 |
| Tendera, M | 2 |
| Wodniecki, J | 2 |
| Krzywiecki, A | 1 |
| Podszus, Th | 1 |
| Peter, JH | 1 |
| Völger, KD | 1 |
| Zilles, P | 1 |
| Zhao, L | 1 |
| Gassner, A | 1 |
| Sommer, G | 1 |
| Fridrich, L | 1 |
| Magometschnigg, D | 1 |
| Priol, A | 1 |
| Palombo, C | 1 |
| Mian, M | 1 |
| Bertelli, A | 1 |
| Schauer, J | 1 |
| Himmel, W | 1 |
| Orschekowski, H | 1 |
| Marozsán, I | 1 |
| Szatmáry, L | 1 |
| Kelemen, S | 1 |
| Farrukh, IS | 1 |
| Gurtner, GH | 1 |
| Michael, JR | 1 |
| Sil'vestrov, VP | 1 |
| Surovov, IuA | 1 |
| Semin, SN | 1 |
| Pakulin, IA | 1 |
| Larin, NV | 1 |
| Dubiel, JP | 3 |
| Brzostek, T | 3 |
| Zmudka, K | 3 |
| Bielecki, A | 2 |
| Pudelski, J | 1 |
| Kardaszewicz, P | 1 |
| Brimkulov, NN | 1 |
| Smallbone, BW | 1 |
| Davies, BJ | 1 |
| Noulty, EJ | 1 |
| Pisters, LL | 1 |
| Taylor, NE | 1 |
| McDonald, JW | 1 |
| Winniford, MD | 1 |
| Hillis, LD | 1 |
| O'Brien, JT | 1 |
| Hill, JA | 1 |
| Pepine, CJ | 1 |
| Malcić, I | 1 |
| Richter, D | 1 |
| Rubin, LJ | 1 |
| Degenring, FH | 1 |
| Both, A | 1 |
8 reviews available for verapamil and Pulmonary Hypertension
| Article | Year |
|---|---|
[Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
Topics: Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels; Humans; Hypertension, Pulmonary | 2012 |
Understanding the calcium channel blockers.
Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu | 1984 |
Clinical value of calcium antagonists in treatment of cardiovascular disorders.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calciu | 1983 |
Clinical applications of slow channel blocking compounds.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Platelets; Blood Vessels; Calcium | 1983 |
Persistent pulmonary hypertension of the neonate (persistent fetal circulation syndrome).
Topics: Acetylcholine; Calcium; Catecholamines; Epoprostenol; Homeostasis; Humans; Hypertension, Pulmonary; | 1983 |
[Calcium antagonists: accounts on new perspectives of their use and an update on side effects].
Topics: Adult; Animals; Asthma; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Esophageal Ach | 1989 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
Therapeutic application of calcium-channel antagonists for pulmonary hypertension.
Topics: Animals; Calcium Channel Blockers; Cattle; Diltiazem; Hemodynamics; Humans; Hypertension, Pulmonary; | 1985 |
4 trials available for verapamil and Pulmonary Hypertension
| Article | Year |
|---|---|
Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Double-Blind Method; Forced Expiratory Volume; Humans; Hypertension, Pul | 2022 |
[The possibilities of isoptin treatment of pulmonary hypertension in patients with chronic obstructive bronchitis].
Topics: Adult; Aged; Bronchitis; Calcium Channel Blockers; Chronic Disease; Female; Humans; Hypertension, Pu | 1997 |
Verapamil and pulmonary hypertension.
Topics: Adult; Aged; Arterioles; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Evaluation; | 1978 |
[Modification of pulmonary hypertension in patients with chronic obstructive lung diseases using calcium antagonists in an acute trial].
Topics: Administration, Sublingual; Adult; Aged; Clinical Trials as Topic; Humans; Hypertension, Pulmonary; | 1989 |
39 other studies available for verapamil and Pulmonary Hypertension
| Article | Year |
|---|---|
Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Furosemide; | 2008 |
Calcium antagonist verapamil prevented pulmonary arterial hypertension in broilers with ascites by arresting pulmonary vascular remodeling.
Topics: Animals; Ascites; Blood Pressure; Calcium Channel Blockers; Calcium Signaling; Chickens; Erythrocyte | 2007 |
[Verapamil in rats exposed to intermittent altitude hypoxia. Its effect on pulmonary hypertension, right ventricular hypertrophy and myocardial necroses (author's transl)].
Topics: Animals; Cardiomegaly; Hypertension, Pulmonary; Hypoxia; Male; Myocardium; Necrosis; Rats; Rats, Inb | 1981 |
Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy induced in rats by intermittent high altitude hypoxia.
Topics: Altitude Sickness; Animals; Body Weight; Cardiomegaly; Hematocrit; Hemodynamics; Hemoglobins; Hypert | 1981 |
Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
Topics: Adult; Calcium Channel Blockers; Cardiac Output; Exercise Test; Female; Hemodynamics; Humans; Hydral | 1984 |
The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet.
Topics: Animals; Animals, Newborn; Cardiac Output; Hypertension, Pulmonary; Hypoxia; Nifedipine; Pulmonary W | 1984 |
Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Topics: Animals; Benzazepines; Blood Pressure; Cardiac Output; Diltiazem; Dinoprost; Dogs; Dose-Response Rel | 1983 |
Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists.
Topics: Animals; Dimethyl Sulfoxide; Hydralazine; Hypertension, Pulmonary; Hypoxia; Male; Nifedipine; Pulmon | 1984 |
Detrimental effects of verapamil in patients with primary pulmonary hypertension.
Topics: Adult; Depression, Chemical; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension, Pulmonary | 1984 |
Calcium antagonists in heart failure.
Topics: Aortic Valve Insufficiency; Calcium Channel Blockers; Coronary Disease; Diltiazem; Heart Failure; He | 1983 |
[Verapamil (an antagonist of calcium) and its effect on chronic pulmonary hypertension in humans].
Topics: Blood Pressure; Calcium Channel Blockers; Chronic Disease; Humans; Hypertension, Pulmonary; Verapami | 1982 |
[Case of primary pulmonary hypertension, an attempt at vasodilator therapy].
Topics: Adult; Female; Humans; Hypertension, Pulmonary; Pulmonary Circulation; Respiratory Function Tests; V | 1982 |
[Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)].
Topics: Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Isoproterenol; Lung Diseases, Obstructi | 1981 |
[Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
Topics: Adult; Aminophylline; Bronchitis; Chronic Disease; Humans; Hydralazine; Hypertension, Pulmonary; Mid | 1994 |
Contribution of chloride channel activation to the elevated muscular tone of the pulmonary artery in monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Base Sequence; Calcium; Chloride Channels; Cytosol; DNA Primers; Hypertension, Pulmonary; M | 2001 |
Halothane differentially decreases 5-hydroxytryptamine-induced contractions in normal and chronic hypoxic rat pulmonary arteries.
Topics: Anesthetics, Inhalation; Animals; Cadmium; Calcium Channel Blockers; Chronic Disease; Halothane; Hyp | 2001 |
The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Cardiopulm | 2002 |
Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.
Topics: Animals; Aspirin; Biological Transport; Calcium; Cardiomegaly; Chronic Disease; Female; Haplorhini; | 1979 |
Pulmonary vascular effects of verapamil.
Topics: Altitude; Animals; Blood Pressure; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary Circulation; Ra | 1978 |
Reduction of bovine pulmonary hypertension by normoxia, verapamil and hexoprenaline.
Topics: Airway Resistance; Animals; Blood Pressure; Calcium; Cattle; Hexoprenaline; Hypertension, Pulmonary; | 1977 |
[Verapamil and nifedipine limit hemodynamic changes in pulmonary circulation in rats with hypoxia].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Depression, Chemical; Disease Models, Animal; Hype | 1991 |
[Combination therapy in chronic heart failure. Hemodynamic effects with a calcium antagonist-diuretic combination].
Topics: Adult; Aged; Chronic Disease; Drug Combinations; Heart Failure; Hemodynamics; Humans; Hydrochlorothi | 1991 |
[Prevention of hypoxic pulmonary hypertension with "qi-xue" injection].
Topics: Animals; Drugs, Chinese Herbal; Hypertension, Pulmonary; Hypoxia; Injections; Male; Panax; Plants, M | 1990 |
Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil.
Topics: Calcium Channel Blockers; Diltiazem; Exercise Test; Hemodynamics; Humans; Hypertension, Pulmonary; L | 1990 |
[The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension].
Topics: Adult; Bronchitis; Calcium Channel Blockers; Chronic Disease; Drug Evaluation; Female; Hemodynamics; | 1989 |
[Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease].
Topics: Adult; Blood Pressure; Female; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Middle A | 1989 |
Pharmacological modification of pulmonary vascular injury: possible role of cAMP.
Topics: Alprostadil; Animals; Cell Membrane Permeability; Cyclic AMP; Hypertension, Pulmonary; Indomethacin; | 1987 |
[Corrective effect of nitrates and calcium antagonists on hemodynamics and ventilation in chronic bronchitis patients with a syndrome of pulmonary hypertension].
Topics: Bronchitis; Calcium Channel Blockers; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension, | 1987 |
Pulmonary artery pressure changes in primary pulmonary hypertension after verapamil and oxygen.
Topics: Adult; Cardiac Output; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Oxygen Inhalation | 1988 |
[Hemodynamic effect of a single intravenous dose of verapamil in patients with hypoxemic pulmonary hypertension].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; | 1988 |
Influence of verapamil and oxygen on pulmonary hypertension and right ventricular function.
Topics: Humans; Hypertension, Pulmonary; Myocardial Contraction; Oxygen; Pulmonary Circulation; Pulmonary We | 1988 |
[Acute hemodynamic effects of finoptin in patients with bronchial asthma complicated by pulmonary hypertension].
Topics: Adult; Asthma; Blood Pressure; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle A | 1987 |
[Differences in the effect of verapamil on pulmonary circulation in primary pulmonary hypertension].
Topics: Adult; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Monitoring, Physiologic; Pulmonar | 1987 |
Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Complement Activation; Female; Hypertension, Pulmonary; Hypox | 1986 |
Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis.
Topics: Female; Humans; Hypertension, Pulmonary; Middle Aged; Scleroderma, Systemic; Verapamil | 1985 |
Verapamil in primary pulmonary hypertension.
Topics: Blood Pressure; Child; Electrocardiography; Female; Hemodynamics; Humans; Hypertension, Pulmonary; V | 1985 |
Calcium channel blockers in primary pulmonary hypertension.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Hypertension, Pulmonary; Nifedipine; Verapamil | 1985 |
[The therapeutic modification of the primary vascular form of chronic cor pulmonale and of continuing pulmonary hypertension after commissurotomy for mitral stenosis. A comparison with control of the pulmonary artery pressure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Cardi | 1970 |
[Therapy of primary pulmonary hypertension].
Topics: Acetylcholine; Amino Alcohols; Carbachol; Child; Diazepam; Diazoxide; Female; Humans; Hypertension, | 1970 |